(Q41450890)

30 September 2017

1 reference

title

Prostate-specific membrane antigen and other prostatic tumor markers on the horizon (English)

1 reference

30 September 2017

Israeli RS

1

1 reference

30 September 2017

Grob M

series ordinal

2

1 reference

30 September 2017

Fair WR

series ordinal

3

1 reference

30 September 2017

language of work or name

1 reference

1 May 1997

1 reference

Urologic Clinics of North America

30 September 2017

published in

1 reference

30 September 2017

volume

24

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

439-450

1 reference

Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Implications of the p53 tumor-suppressor gene in clinical oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Prostate-specific membrane antigen: evidence for the existence of a second related human gene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Molecular cloning of human prostate specific antigen cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Dunning rat prostate tumors and cultured cell lines fail to express human prostate carcinoma-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Topology of eukaryotic type II membrane proteins: importance of N-terminal positively charged residues flanking the hydrophobic domain

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Selective stimulation of prostatic carcinoma cell proliferation by transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Transcending the impenetrable: how proteins come to terms with membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Angiogenesis induced by degradation products of hyaluronic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

Immunohistochemical evaluation of the expression of prostate tumor-association markers in the nude mouse human prostate carcinoma heterotransplant lines PC-82, PC-EW, and PC-EG

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970391-8

7 January 2021

10.1016/S0094-0143(05)70391-8

Identifiers

DOI

1 reference

30 September 2017

1 reference